COMPLETE SOLARIA INC (CSLR)

US20460L1044 - Common Stock

2.9  -0.1 (-3.33%)

Premarket: 3 +0.1 (+3.45%)

Fundamental Rating

1

Overall CSLR gets a fundamental rating of 1 out of 10. We evaluated CSLR against 91 industry peers in the Electrical Equipment industry. CSLR may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CSLR is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year CSLR has reported negative net income.
CSLR had a negative operating cash flow in the past year.

1.2 Ratios

With a Return On Assets value of -778.67%, CSLR is not doing good in the industry: 97.75% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -778.67%
ROE N/A
ROIC N/A
ROA(3y)-188.81%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CSLR has a Gross Margin (17.24%) which is comparable to the rest of the industry.
CSLR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

CSLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CSLR has more shares outstanding
CSLR has a worse debt/assets ratio than last year.

2.2 Solvency

CSLR has an Altman-Z score of -20.85. This is a bad value and indicates that CSLR is not financially healthy and even has some risk of bankruptcy.
CSLR has a Altman-Z score of -20.85. This is amonst the worse of the industry: CSLR underperforms 94.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -20.85
ROIC/WACCN/A
WACC10.08%

2.3 Liquidity

A Current Ratio of 0.21 indicates that CSLR may have some problems paying its short term obligations.
The Current ratio of CSLR (0.21) is worse than 94.38% of its industry peers.
A Quick Ratio of 0.19 indicates that CSLR may have some problems paying its short term obligations.
CSLR has a Quick ratio of 0.19. This is amonst the worse of the industry: CSLR underperforms 94.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.19

4

3. Growth

3.1 Past

CSLR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -686.25%.
CSLR shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.50%.
EPS 1Y (TTM)-686.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.9%
Revenue 1Y (TTM)41.5%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-89.38%

3.2 Future

Based on estimates for the next years, CSLR will show a very strong growth in Earnings Per Share. The EPS will grow by 32.24% on average per year.
The Revenue is expected to grow by 18.38% on average over the next years. This is quite good.
EPS Next Y65.63%
EPS Next 2Y41.23%
EPS Next 3Y31.72%
EPS Next 5Y32.24%
Revenue Next Year-57%
Revenue Next 2Y-5.65%
Revenue Next 3Y15.16%
Revenue Next 5Y18.38%

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSLR. In the last year negative earnings were reported.
Also next year CSLR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CSLR's earnings are expected to grow with 31.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.23%
EPS Next 3Y31.72%

0

5. Dividend

5.1 Amount

CSLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COMPLETE SOLARIA INC

NASDAQ:CSLR (9/26/2024, 8:00:00 PM)

Premarket: 3 +0.1 (+3.45%)

2.9

-0.1 (-3.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap184.47M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -778.67%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 17.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.21
Quick Ratio 0.19
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-686.25%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y65.63%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)41.5%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y